Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Curium, Eli Lilly, Eupraxia, Gilead, GSK, Idrx, Immunic, ImmunoCure, Immutep, Inovio, Nuvectis, Sparian, AC Immune, Mediprint, Microbion, Nobias, X4.